Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells

Pancreatic Ductal Adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by rapid progression, invasiveness and resistance to treatment. We have previously demonstrated that most PDAC patients have circulating antibodies against the glycolytic enzyme alpha-enolase (ENO1), which correl...

Descripción completa

Detalles Bibliográficos
Autores principales: Principe, Moitza, Ceruti, Patrizia, Shih, Neng-Yao, Chattaragada, Michelle S., Rolla, Simona, Conti, Laura, Bestagno, Marco, Zentilin, Lorena, Yang, Sheng-Hui, Migliorini, Paola, Cappello, Paola, Burrone, Oscar, Novelli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484442/
https://www.ncbi.nlm.nih.gov/pubmed/25860938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484442/
https://www.ncbi.nlm.nih.gov/pubmed/25860938

Ejemplares similares